dividendsafetychecker.com

Royalty Pharma plc - Class ARPRX

Unknown · Biotechnology

Safe
Cuts are rare here: roughly 1 in 100 stocks with this rating cut within a year

Scored 2026-07-08 · updates weekly

71.6SAFE0100

What’s driving the score

Dividend yield27%
97
Yield vs its own history20%
100
Interest coverage9%
85
Free cash flow payout9%
98
Years since last cut9%
64
Dividend growth (1y)7%
100
Cash flow payout5%
97
Profit steadiness4%
45
Earnings payout4%
88
Debt load3%
79
Revenue growth3%
100
Cash vs debt1%
72

100 is the best score. The small percentage shows how much each factor counts. Hover a factor name for what it means. “n/a” means that factor doesn’t apply to this type of company (banks and REITs work differently), so the other factors count more.

The bottom line

As of 2026-07-08, Royalty Pharma plc - (RPRX) scores 71.6 out of 100 on the Dividend Safety Checker scale, which rates its dividend Safe. In our testing, roughly 1 in 100 stocks with this rating cut their dividend within a year.

The strongest parts of the picture are revenue growth, yield vs its own history, dividend growth (1y). The main things holding the score back are profit steadiness (scoring 45 out of 100) and years since last cut (64 out of 100). How steady quarterly profits have been over the past 3 years. Wobbly profits make payouts fragile.

Royalty Pharma plc - currently yields 1.6%, last cut its dividend about 6 years ago, pays out 15% of its free cash flow as dividends. The score updates weekly as new filings and prices come in.

Common questions

Is Royalty Pharma plc -'s dividend safe?

As of 2026-07-08, Royalty Pharma plc - (RPRX) scores 71.6 out of 100 on the Dividend Safety Checker scale, which rates its dividend Safe. In our testing, roughly 1 in 100 stocks with this rating cut their dividend within a year.

How likely is RPRX to cut its dividend in the next 12 months?

Royalty Pharma plc - is rated Safe (score 71.6 of 100). In our testing, roughly 1 in 100 stocks with this rating cut their dividend within a year. The rating comes from a formula tested against every US dividend cut from 2008 to 2025.

When did Royalty Pharma plc - last cut its dividend?

Royalty Pharma plc -'s last dividend cut was about 6 years ago, based on its payment history.

What is Royalty Pharma plc -'s dividend yield?

As of 2026-07-08, Royalty Pharma plc - yields 1.6% based on its trailing 12 months of regular dividend payments.

How is this dividend safety score calculated?

The score combines 12 measurable factors: payout ratios, debt, profit steadiness, yield versus the stock's own history, and the company's cut record. Each factor is graded against 18 years of real dividend-cut history. The full method is public at dividendsafetychecker.com/methodology.

Answers are generated from the latest model run and refresh with each rescore. Not investment advice. See how the score works.

Get a free alert if Royalty Pharma plc -'s rating drops

We recheck RPRX and every stock we track each week. When any of them gets downgraded, subscribers hear about it first. No spam, unsubscribe anytime.

Share it

Download the score card as an image to post or send.

Royalty Pharma plc - Class ARPRXDividend safety check · 2026-07-08SafeCuts are rare here: roughly 1 in 100 stocks withthis rating cut within a year71.6SAFE0100What’s driving the score100 = safestDividend yield97Yield vs its own history100Interest coverage85Free cash flow payout98Years since last cut64Dividend growth (1y)100Cash flow payout97Profit steadiness45Earnings payout88Debt load79Revenue growth100Cash vs debt72Free score for any US stock. Not investment advice.dividendsafetychecker.com

Want to know how this is calculated? The whole method is public, and so is its track record. Or browse more Unknown dividend stocks.

Is Royalty Pharma plc -'s (RPRX) Dividend Safe? Score: 71.6, Safe | Dividend Safety Checker